When UConn School of Social Work Assistant Professor Gio Iacono was a mental health clinician working with LGBTQIA+ youth, he searched for programs and interventions that would help him better serve his clients who were struggling ...
Sep 19, 2023
0
22
Children who lived closer to natural gas wells in heavily drilled western Pennsylvania were more likely to develop a relatively rare form of cancer, and nearby residents of all ages had an increased chance of severe asthma ...
Aug 15, 2023
0
10
School-based depression prevention programs may reduce the risk of depression diagnoses and depressive symptoms in K-12 students, according to new findings from University of Oregon researchers.
Apr 26, 2023
0
2
Instead of special heart scans, physicians can use images of the chest captured months earlier for other reasons to estimate patients' risk of heart attack or death during several kinds of major surgeries, a new study shows.
Mar 2, 2023
0
2
Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines—such as doxorubicin, frequently used against breast cancer—kill ...
Dec 27, 2022
0
74
NFL players age nearly a decade faster than the general population and suffer from arthritis and high blood pressure as early as their 20s, according to a new study from Harvard Medical School.
Dec 12, 2022
0
3
In patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of the investigational AKT inhibitor capivasertib to fulvestrant (Faslodex) doubled the median progression-free ...
Dec 8, 2022
0
6
Major emergencies such as terrorist attacks and natural disasters have become more complex and larger in scale, challenging the ability of first responders to deal with the overwhelming numbers of casualties. As they battle ...
Nov 18, 2022
0
2
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia, affecting more than 5.8 million individuals in the U.S. Scientists have discovered some genetic variants that increase ...
Jun 23, 2022
0
85
An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness.
Jun 13, 2022
0
7
